v1
A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma.
Identifier:nobleid.org/w1/20260515/27B03CC3
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/27B03CC3)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims